A
Alice M. Mascette
Researcher at National Institutes of Health
Publications - 21
Citations - 5746
Alice M. Mascette is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 18, co-authored 21 publications receiving 5110 citations. Previous affiliations of Alice M. Mascette include Agency for Healthcare Research and Quality.
Papers
More filters
Journal ArticleDOI
Diuretic Strategies in Patients with Acute Decompensated Heart Failure
G. Michael Felker,Kerry L. Lee,David A. Bull,Margaret M. Redfield,Lynne W. Stevenson,Steven R. Goldsmith,Martin M. LeWinter,Anita Deswal,Jean L. Rouleau,Elizabeth Ofili,Kevin J. Anstrom,Adrian F. Hernandez,Steven McNulty,Eric J. Velazquez,Abdallah G. Kfoury,Horng H. Chen,Michael M. Givertz,Marc J. Semigran,Bradley A. Bart,Alice M. Mascette,Eugene Braunwald,Christopher M. O'Connor +21 more
TL;DR: Among patients with acute decompensated heart failure, there were no significant differences in patients' global assessment of symptoms or in the change in renal function when diuretic therapy was administered by bolus as compared with continuous infusion or at a high dose asCompared with a low dose.
Journal ArticleDOI
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial
Margaret M. Redfield,Horng H. Chen,Barry A. Borlaug,Marc J. Semigran,Kerry L. Lee,Gregory D. Lewis,Martin M. LeWinter,Jean L. Rouleau,David A. Bull,Douglas L. Mann,Anita Deswal,Lynne W. Stevenson,Michael M. Givertz Elizabeth O Ofili,Michael M. Givertz Elizabeth O Ofili,Christopher M. O'Connor,G. Michael Felker,Steven R. Goldsmith,Bradley A. Bart,Steven McNulty,Jenny C. Ibarra,Grace Lin,Jae K. Oh,Manesh R. Patel,Raymond J. Kim,Russell P. Tracy,Eric J. Velazquez,Kevin J. Anstrom,Adrian F. Hernandez,Alice M. Mascette,Eugene Braunwald +29 more
TL;DR: Among patients with HFPEF, phosphodiesterase-5 inhibition with administration of sildenafil for 24 weeks, compared with placebo, did not result in significant improvement in exercise capacity or clinical status.
Journal ArticleDOI
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
Bradley A. Bart,Steven R. Goldsmith,Kerry L. Lee,Michael M. Givertz,Christopher M. O'Connor,David A. Bull,Margaret M. Redfield,Anita Deswal,Jean L. Rouleau,Martin M. LeWinter,Elizabeth Ofili,Lynne W. Stevenson,Marc J. Semigran,G. Michael Felker,Horng H. Chen,Adrian F. Hernandez,Kevin J. Anstrom,Steven McNulty,Eric J. Velazquez,Jenny C. Ibarra,Alice M. Mascette,Eugene Braunwald +21 more
TL;DR: In a randomized trial involving patients hospitalized for acute decompensated heart failure, worsened renal function, and persistent congestion, the use of a stepped pharmacologic-therapy algorithm was superior to a strategy of ultrafiltration for the preservation of renal function at 96 hours, with a similar amount of weight loss with the two approaches.
Journal ArticleDOI
Coronary intervention for persistent occlusion after myocardial infarction.
Judith S. Hochman,Gervasio A. Lamas,Christopher E. Buller,Vladimir Dzavik,Harmony R. Reynolds,Staci J. Abramsky,Sandra A. Forman,Witold Rużyłło,Aldo P. Maggioni,Harvey D. White,Zygmunt Sadowski,Antonio Carlos Carvalho,Jamie Rankin,Jean Renkin,P. Gabriel Steg,Alice M. Mascette,George Sopko,Matthias Pfisterer,Jonathan Leor,Viliam Fridrich,Daniel B. Mark,Genell L. Knatterud +21 more
TL;DR: PCI did not reduce the occurrence of death, reinFarction, or heart failure, and there was a trend toward excess reinfarction during 4 years of follow-up in stable patients with occlusion of the infarct-related artery 3 to 28 days after myocardial infarction.
Journal ArticleDOI
Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop
Glenn I. Fishman,Sumeet S. Chugh,John P. DiMarco,Christine M. Albert,Mark E. Anderson,Robert O. Bonow,Alfred E. Buxton,Peng Sheng Chen,Mark Estes,Xavier Jouven,Raymond Y. Kwong,David A. Lathrop,Alice M. Mascette,Jeanne M. Nerbonne,Brian O'Rourke,Richard L. Page,Dan M. Roden,David S. Rosenbaum,Nona Sotoodehnia,Natalia A. Trayanova,Zhi Jie Zheng +20 more
TL;DR: In this paper, the authors proposed a method for predicting and preventing sudden cardiac death (SCD) in the general population, which can manifest as ventricular tachycardia, ventricular fibrillation (VF), pulseless electric activity (PEA), or asystole.